Search

everythinglearnresearchcommunity

for

Search:↓

New dermoscopic criteria accurately diagnose and grade the severity of hair loss in androgenetic alopecia.

Platelet-rich plasma injections significantly improve hair density and thickness in both male and female pattern hair loss, especially in early stages.

Oral antiandrogens effectively treat female hair loss, with better results in higher hair loss grades.

Higher concentration of botulinum toxin A is safe and effective for treating hair loss in men and women.

Trichoscopy effectively diagnoses early female hair loss, but may need scalp biopsy for confirmation.

The antiandrogen 11α-hydroxyprogesterone effectively reduces skin oil and cholesterol when applied to the skin.

Many COVID-19 survivors experience long-term symptoms but still report satisfactory quality of life and return to work.

Ozenoxacin 1% cream is an effective and safe treatment for impetigo in children and adults.

FPHL common in Taiwanese women; risk factors include BMI, high glucose, early puberty, fewer childbirths, oral contraceptives, and UV exposure.

The BASP classification is a detailed and accurate way to categorize hair loss in both men and women.

Finasteride improves hair density and thickness in women with hair loss.

Growth factors and microneedle therapy increase hair density in women with hair loss.

Some psychiatric drugs can cause severe hair loss, especially valproic acid, and it's more likely in women or those with thyroid issues or past hair loss.

"Male-pattern" hair loss is common in women, especially after menopause, and doesn't always mean there's a problem with hormone balance.

Using human fat tissue derived stem cells in micrografts can safely and effectively increase hair density in people with hair loss.

Japanese women typically start experiencing hair loss after 40, with reduced hair density and thickness being the main factors.

Female pattern hair loss can be treated with medications, surgery, and cosmetic products, considering its psychological impact.

Finasteride can slow hair loss and promote growth in postmenopausal women.

Combining low-level light therapy and minoxidil 5% is more effective for female hair loss than using either treatment alone.

The hair shedding scale accurately identifies abnormal hair shedding in women with long hair, with grades 5 and 6 indicating excessive shedding.

Acne severity in women may not be linked to increased male hormone indicators like excess body hair, menstrual irregularities, or hair loss.

The BASP classification is more reliable than the Norwood-Hamilton for classifying hair loss in men and women.

Female pattern hair loss involves thinning hair on crown and frontal scalp, diagnosed by hair ratio, and treated with minoxidil, antiandrogens, or hair transplantation.

Mesenchymal stem cell-derived exosomes significantly increase hair density and thickness in androgenic alopecia patients.

Older age, family history, and low iron levels increase the risk of female hair loss.

Skin problems like excessive hair growth, acne, and dark skin patches can be signs of Polycystic Ovarian Disease, which may also be linked to family history and a risk for diabetes.

The Rotterdam Study aims to understand disease causes in the elderly and has found new risk factors and genetic influences on various conditions.

Finasteride doesn't effectively treat hair loss in postmenopausal women.

Minoxidil, finasteride, and low-level laser light therapy effectively treat hair loss.

Aromatase gene variation may increase female hair loss risk.